MedPath

Efficacy of different schemes of supplementation with micronutrient powder for the control of anemia and micronutrient deficiency in childre

Completed
Conditions
Anemia
Nutritional, Metabolic, Endocrine
Registration Number
ISRCTN47136464
Lead Sponsor
Micronutrient Initiative (Canada)
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
400
Inclusion Criteria

1. Children between 6 months and 11 months and 29 days old
2. Residents in the city of Cajamarca and communities near the Health Center Baños del Inca
3. Born at term
4. Birth weight = 2500 g
5. Healthy
6. Hemoglobin> 8 g/dL (corrected for altitude)
7. Weight / length> -2 SD
8. Parents agree and sign the informed consent form

Exclusion Criteria

1. Children younger than 6 months, or more than 12 months
2. Non-residents in Cajamarca (intervention site)
3. Children with initial hemoglobin below 8 g/dL (corrected for altitude) will be evaluated by the doctor to discard additional pathology and will be treated according to Ministry of Health standards
4. Weight/length below - 2 DE
5. Chronic, congenital or severe diseases
6. Parents do not sign the informed consent form

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Anemia prevalence. All children are followed for 12 months, at entry and every month children are examined by a pediatrician at the outpatient clinic, every 2 weeks a field worker visits the child´s home to record compliance and morbidity, at entry and at the end of supplementation a venous blood sample of 5 ml is taken to measure hemoglobin, and micronutrients. In 2 more times we will take a drop of blood from the finger to measure hemoglobin.
Secondary Outcome Measures
NameTimeMethod
1. Growth (weight and length)<br>2. diarrhea prevalence<br>3. micronutrient status (ferritin, transferrin receptors)<br>4. vitamin A<br>5. vitamin B12<br>6. zinc and folate status<br>7. inflamatory markers (CRP, AGP)
© Copyright 2025. All Rights Reserved by MedPath